Global Cancer Tumor Profiling Market 2022 by Company, Regions, Type and Application, Forecast to 2028

40550
Present Value (M$)
2021
78790
Forecast Value (M$)
2028
10%
CAGR (%)

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Cancer Tumor Profiling market size is estimated to be worth US$ 40550 million in 2021 and is forecast to a readjusted size of USD 78790 million by 2028 with a CAGR of 10.0% during review period.

Main companies

  • Qiagen N.V.
  • Roche Molecular Systems Inc.
  • Abott Molecular
  • Illumina Inc.
  • NeoGenomics Laboratories